ACET · Adicet Bio, Inc.

$8.25 +0.05 (+0.61%)

Market Cap

$76.66M

9.35M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Chen Schor	CEO	$646,294	—	—	$512,079	$284,592	$22,782	$1,465,747
Julia Maltzman	Chief Medical Officer	$452,308	—	—	$502,605	$153,600	$16,290	$1,124,803
Blake Aftab	Chief Scientific Officer	$484,720	—	—	$184,367	$155,232	$91,170	$915,489

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Chen Schor	CEO	$627,594	—	$168,720	$3,587,633	$241,780	$18,638	$4,644,365
Francesco Galimi	Chief Medical Officer	$485,150	—	$63,120	$849,591	—	$449,911	$1,847,772
Nick Harvey	CFO	$461,694	—	$63,120	$849,165	$129,360	$20,087	$1,523,426
Blake Aftab	Chief Scientific Officer	$470,692	—	$47,280	$732,479	$131,880	$91,245	$1,473,576

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Chen Schor	CEO	$606,052	—	$773,775	$4,328,064	$250,346	$15,570	$5,973,807
Nick Harvey	CFO	$445,538	—	$236,205	$1,301,545	$133,830	$15,570	$2,132,688
Donald Healey	CTO	$454,267	—	$236,205	$1,246,917	$136,500	$15,570	$2,089,460

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Chen Schor	CEO	$562,285	—	—	$3,088,443	$309,540	$27,751	$3,988,018
Blake Aftab	Chief Scientific Officer	$401,769	—	—	$1,804,505	$182,600	$90,670	$2,479,544
Francesco Galimi	Chief Medical Officer	$443,404	—	—	$1,308,662	$195,360	$41,601	$1,989,027

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Chen Schor	CEO	$535,754	—	$1,951,200	$6,939,024	$321,600	$9,420	$9,756,998
Nick Harvey	CFO	$396,815	—	$650,400	$1,131,835	$190,560	$9,420	$2,379,030
Francesco Galimi	Chief Medical Officer	$412,800	—	$650,400	$1,039,071	$198,240	$40,349	$2,340,860

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Chen Schor	CEO	$499,216	—	$815,280	$9,710,925	$212,167	$38,700	$11,276,287
Lloyd Klickstein	Chief Scientific Officer	$397,608	—	$280,186	$2,202,885	—	$16,671	$2,897,351
Francesco Galimi	CTO	$389,212	$162,500	—	$821,610	$115,790	$38,677	$1,527,789
Anil Singhal	CEO	$338,038	—	—	$100,982	$211,500	$754,000	$1,404,520

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Chen Schor	CEO	$479,167	—	$436,880	$1,664,646	$189,150	$8,400	$2,778,243
Anil Singhal	CEO	$307,992	—	—	$2,215,879	$110,877	$69,183	$2,703,931
Lloyd Klickstein	Chief Scientific Officer	$248,182	—	$150,142	$1,933,455	$77,675	$5,869	$2,415,323
Joan Mannick	Chief Medical Officer	$385,000	—	$150,142	$699,641	$121,680	$8,400	$1,364,863
Francesco Galimi	Chief Medical Officer	$105,000	$162,500	—	$347,480	$29,400	$15,370	$659,750

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Chen Schor	CEO	$443,201	—	—	$2,418,450	$225,000	$8,250	$3,094,901
Joan Mannick	Chief Medical Officer	$356,811	—	—	$943,781	$144,000	$8,400	$1,452,992

Key facts CIK 1720580 CUSIP 007002207 13F (30d) 2 filings 2 filers Visit website Investor relations